Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ...

Platinum Pro is Quantum-Si’s newest Next-Generation Protein Sequencer™ built from the foundation of innovation established by ...

Request To Download Free Sample of This Strategic Report @ The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global ...

The Next-Generation Cancer Diagnostics Market is experiencing robust growth, as indicated by a Compound Annual Growth Rate (CAGR) of 18.9% projected from 2022 to 2028. This surge in market value is ...

The global next generation molecular assay market is poised for significant growth, with an expected valuation of USD ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

This meta-analysis sheds more light on the beneficial impact of multiple melanoma (MM) treatments and the predictive value of ...

Illumina, Inc. ILMN has announced a collaboration with NVIDIA NVDA to advance technology platforms for analyzing and interpreting multiomic data. By combining advancements in artificial intelligence ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

The PEACE-1 trial (NCT01957436) revealed that adding radiotherapy to standard of care (SOC) and abiraterone significantly ...

Illumina, Inc. , a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic ...

Explore how precision medicine is reshaping healthcare with tools like genetic testing, NGS, wearables, and organoids for ...